Skip to Main Content

Clonal hematopoiesis as a biomarker of poor prognosis in high-grade serous ovarian cancer

Prevalence and Experience of Traumatic Stress in Patients with Newly Diagnosed and Recurrent Advanced Ovarian Cancer

Enabling a Phase I Clinical Trial of a Novel CAR-T Cell Therapy for Ovarian Cancer

Investigating the proteome and secretome of ovarian cancer to inform early detection and treatment

Uncovering targetable interactions of ovarian cancer cells

Adapting the Genetics Adviser digital app to support cascade testing

Molecular and Functional Characterization of a Patient-Derived Organoid Platform for Ovarian Cancer

Testing a novel HER2-targeted combination treatment for ovarian cancer

Syngeneic mouse models: tools to study immune-based treatments for ovarian cancer

The earlier detection of ovarian cancer using an mDETECT liquid biopsy